P8IP
AGN

Pier 88 Investment Partners’s Allergan plc AGN Stock Holding History

Pier 88 Investment Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-176
Closed -$30K – 120
2018
Q1 		$30K Buy
+176
New +$29.5K 0.01% 108

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Pier 88 Investment Partners's AGN Position: Q2 2018 in Review

Pier 88 Investment Partners sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 176 shares — an estimated $30K sold.

Pier 88 Investment Partners first reported a position in AGN in Q1 2018 and held it in 1 quarter. The position peaked at $30K in Q1 2018. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

  • Pier 88 Investment Partners reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
  • Pier 88 Investment Partners sold 176 Allergan plc shares in Q2 2018, an estimated $30K.
  • Pier 88 Investment Partners first reported a position in Allergan plc in Q1 2018 and held it in 1 quarter.
  • Pier 88 Investment Partners's Allergan plc position peaked at $30K in Q1 2018.
  • 1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Pier 88 Investment Partners's 13F filing for Q2 2018, filed 25 Jul 2018.